The NLP in Healthcare and Life Sciences market is poised for substantial growth, projected to reach USD 30.06 billion by 2031, driven by advancements in AI technologies.
According to a report by MarketsandMarkets, the market for Natural Language Processing (NLP) in healthcare was valued at USD 5.92 billion in 2025 and is expected to grow significantly, with a compound annual growth rate (CAGR) of 29.9%. This surge is primarily fueled by the increasing integration of large language models and generative AI into healthcare systems. Organizations across the sector, including healthcare providers, payers, and pharmaceutical companies, are leveraging NLP to extract valuable insights from unstructured data sources like electronic health records and clinical trial documents.
In terms of market segments, the software category is anticipated to dominate by 2026, as healthcare entities adopt AI-driven platforms for clinical documentation and workflow automation. The life sciences sector is projected to experience the highest growth rate, particularly as AI technologies accelerate drug discovery and clinical research. Notably, North America is expected to hold the largest market share, benefiting from advanced healthcare infrastructure and significant investments in AI technologies.
This market expansion underscores the critical role of NLP in enhancing clinical outcomes and operational efficiency. As healthcare organizations continue to embrace digital transformation, the demand for specialized NLP solutions that can accurately interpret medical terminologies and improve data usability will likely grow, positioning vendors who innovate in this space for success.